Apogee Enterprises, Inc. (APOG)

Achilles Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Achilles Therapeutics stock has a target of 45, which predicts a 7.97% increase from the current stock price of 41.68.

Price Target: $45.00 (+7.97%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$45	$45	$45	$45
Change	+7.97%	+7.97%	+7.97%	+7.97%

* Price targets were last updated on Jul 1, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Achilles Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brent Thielman DA Davidson	DA Davidson	Hold Maintains $47 → $45	Hold	Maintains	$47 → $45	+7.97%	Jul 1, 2025
Brent Thielman DA Davidson	DA Davidson	Hold Maintains $75 → $62	Hold	Maintains	$75 → $62	+48.75%	Jan 8, 2025
Brent Thielman DA Davidson	DA Davidson	Hold Maintains $65 → $75	Hold	Maintains	$65 → $75	+79.94%	Oct 8, 2024
Brent Thielman DA Davidson	DA Davidson	Hold Maintains $60 → $65	Hold	Maintains	$60 → $65	+55.95%	Jun 28, 2024
Eric Stine Craig-Hallum	Craig-Hallum	Hold Maintains $45 → $46	Hold	Maintains	$45 → $46	+10.36%	Apr 13, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

1.45B

Increased by 6.76%

from 1.36B

Revenue Next Year

1.45B

Decreased by -0.28%

from 1.45B

EPS This Year

4.04

Increased by 3.79%

from 3.89

EPS Next Year

4.17

Increased by 3.29%

from 4.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Feb 27, 2021	Feb 26, 2022	Feb 25, 2023	Mar 2, 2024	Mar 1, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	1.23B	1.31B	1.44B	1.42B	1.36B	1.45B	1.45B
Revenue Growth	-11.29%	6.76%	9.64%	-1.65%	-3.95%	6.76%	-0.28%
EPS	0.59	0.14	4.64	4.51	3.89	4.04	4.17
EPS Growth	-74.57%	-76.29%	3,216.96%	-2.80%	-13.75%	3.79%	3.29%
Forward PE	-	-	-	-	-	10.32	9.99
No. Analysts	-	-	-	-	-	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.5B	1.5B
Avg	1.5B	1.4B
Low	1.4B	1.4B

Revenue Growth

Revenue Growth	2026	2027
High	10.6%	4.1%
Avg	6.8%	-0.3%
Low	1.9%	-5.4%

EPS Forecast

EPS	2026	2027
High	4.21	4.44
Avg	4.04	4.17
Low	3.85	3.87

EPS Growth

EPS Growth	2026	2027
High	8.1%	10.0%
Avg	3.8%	3.3%
Low	-1.0%	-4.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.